|
US4965391A
(en)
|
1987-10-23 |
1990-10-23 |
The University Of Michigan |
Radioiodinated phospholipid ether analogues
|
|
US4938949A
(en)
|
1988-09-12 |
1990-07-03 |
University Of New York |
Treatment of damaged bone marrow and dosage units therefor
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
US5411947A
(en)
|
1989-06-28 |
1995-05-02 |
Vestar, Inc. |
Method of converting a drug to an orally available form by covalently bonding a lipid to the drug
|
|
DE4132344A1
(de)
|
1991-09-27 |
1993-04-01 |
Max Planck Gesellschaft |
Verfahren zur herstellung eines arzneimittels zur oralen oder topischen verabreichung bei der behandlung von leishmaniasis
|
|
US5679647A
(en)
|
1993-08-26 |
1997-10-21 |
The Regents Of The University Of California |
Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
|
|
DE4408011C1
(de)
|
1994-03-10 |
1995-11-02 |
Max Delbrueck Centrum |
Pharmazeutisches Mittel zur Tumortherapie
|
|
CA2276284C
(en)
|
1996-12-04 |
2006-10-10 |
The Regents Of The University Of Michigan |
Radioiodinated phospholipid ether analogs and methods of using the same
|
|
US5837283A
(en)
|
1997-03-12 |
1998-11-17 |
The Regents Of The University Of California |
Cationic lipid compositions targeting angiogenic endothelial cells
|
|
ATE437657T1
(de)
|
2004-03-02 |
2009-08-15 |
Cellectar Inc |
Phospholipid-analoga für die behandlung von krebs
|
|
US8540968B2
(en)
|
2004-03-02 |
2013-09-24 |
Cellectar, Inc. |
Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof
|
|
US7632644B2
(en)
|
2004-03-02 |
2009-12-15 |
Cellectar, Inc. |
Imaging and selective retention of phospholipid ether analogs
|
|
EP1773408A2
(en)
|
2004-07-08 |
2007-04-18 |
Cellectar, Llc |
Virtual colonoscopy with radiolabeled phospholipid ether analogs
|
|
MX2007007497A
(es)
|
2004-12-20 |
2008-01-11 |
Cellectar Llc |
Analogos de fosfolipido eter para la deteccion y tratamiento del cancer.
|
|
UA99434C2
(ru)
|
2005-12-19 |
2012-08-27 |
Аетерна Центаріс Гмбх |
Применение производных алкилфосфолипидов со сниженной цитотоксичностью
|
|
US7893286B2
(en)
|
2007-06-01 |
2011-02-22 |
Cellectar, Inc. |
Method for the synthesis of phospholipid ethers
|
|
US8022235B2
(en)
|
2007-06-01 |
2011-09-20 |
Cellectar, Inc. |
Compositions of phospholipid ether boronic acids and esters and methods for their synthesis and use
|
|
EP2222278B1
(en)
|
2007-11-28 |
2015-04-08 |
Celator Pharmaceuticals, Inc. |
Improved taxane delivery system
|
|
US20100120727A1
(en)
|
2008-11-12 |
2010-05-13 |
Kyphia Pharmaceuticals, Inc. |
Eflornithine Prodrugs, Conjugates and Salts, and Methods of Use Thereof
|
|
US20100286510A1
(en)
|
2009-05-11 |
2010-11-11 |
Pinchuk Anatoly |
Use of fluorescent phospholipid ether compounds in biopsies
|
|
ES2549459T3
(es)
|
2009-05-11 |
2015-10-28 |
Cellectar, Inc. |
Compuestos de éter de fosfolípido fluorescentes, composiciones y procedimientos de uso
|
|
US8871181B2
(en)
|
2009-05-11 |
2014-10-28 |
Cellectar, Inc. |
Fluorescent phospholipid ether compounds, compositions, and methods of use
|
|
US7811548B1
(en)
|
2009-05-11 |
2010-10-12 |
Cellectar, Inc. |
Fluorescent phospholipid ether compounds and compositions
|
|
JP6092624B2
(ja)
|
2009-06-12 |
2017-03-08 |
セレクター，インコーポレイティド |
癌の治療並びに癌幹細胞の造影および検出のためのエーテルおよびアルキルリン脂質化合物
|
|
WO2011031919A2
(en)
|
2009-09-11 |
2011-03-17 |
Cellectar, Inc. |
Non-radioactive phospholipid compounds, compositions, and methods of use
|
|
US20140255432A1
(en)
*
|
2011-07-27 |
2014-09-11 |
Ohio State Innovation Foundation |
Silvestrol, silvestrol analogs and uses thereof
|
|
WO2014106826A2
(en)
|
2013-01-07 |
2014-07-10 |
Piramal Enterprises Limited |
Anthracycline analogue and uses thereof
|
|
FR3023290B1
(fr)
|
2014-07-04 |
2016-08-19 |
Pf Medicament |
Derives de flavaglines
|
|
KR102508023B1
(ko)
|
2014-09-03 |
2023-03-10 |
이뮤노젠 아이엔씨 |
세포-결합제 및 세포독성 약물을 포함하는 콘주게이트
|
|
CA2968145C
(en)
|
2014-11-17 |
2023-06-27 |
Cellectar Biosciences, Inc. |
Phospholipid ether analogs as cancer-targeting drug vehicles
|
|
DK3888658T3
(da)
|
2015-11-25 |
2024-03-18 |
Effector Therapeutics Inc |
Eif4-a-inhiberende forbindelser og fremgangsmåder relateret dertil
|
|
EP3439666A4
(en)
|
2016-05-20 |
2019-12-11 |
The University of Chicago |
NANOPARTICLES FOR CHEMOTHERAPY, TARGETED THERAPY, PHOTODYNAMIC THERAPY, IMMUNOTHERAPY AND ALL COMBINATIONS THEREOF
|
|
WO2017214024A1
(en)
*
|
2016-06-06 |
2017-12-14 |
Genentech, Inc. |
Silvestrol antibody-drug conjugates and methods of use
|
|
WO2017218702A1
(en)
|
2016-06-14 |
2017-12-21 |
Cellectar Biosciences, Inc. |
Phospholipid ether analogs for the identification and isolation of circulating tumor cells
|
|
US11286281B2
(en)
|
2017-05-10 |
2022-03-29 |
Zealand Pharma A/S |
Homodetic cyclic peptides targeting alpha-4-beta-7 integrin
|
|
US11167050B2
(en)
|
2017-09-26 |
2021-11-09 |
National University Corporation Chiba University |
Metal complex forming compound, metal complex compound formed thereof, radioactive drug containing the metal complex compound, and method of using and preparing the metal complex compound
|
|
JP7491572B2
(ja)
|
2018-02-07 |
2024-05-28 |
エル．イー．エー．エフ． ホールディングス グループ エルエルシー |
アルファポリグルタミン酸化ペメトレキセドおよびその使用
|
|
CA3095515A1
(en)
*
|
2018-04-10 |
2019-10-17 |
Cellectar Biosciences, Inc. |
Phospholipid-flavagline conjugates and methods of using the same for targeted cancer therapy
|
|
SG11202009990UA
(en)
|
2018-04-16 |
2020-11-27 |
Nihon Mediphysics Co Ltd |
Modified antibody and radioactive metal-labelled antibody
|
|
NZ786360A
(en)
*
|
2019-09-12 |
2025-12-19 |
Cellectar Biosciences Inc |
Phospholipid ether conjugates as cancer-targeting drug vehicles
|
|
BR112022006739B1
(pt)
|
2019-10-10 |
2024-01-23 |
Cellectar Biosciences, Inc |
Conjugados fosfolipídio-flavagina e métodos de uso do mesmo para terapia direcionada a câncer
|